Regular aspirin use may reduce risk of dying from prostate cancer
Regular aspirin use may reduce risk of dying from prostate cancer
ASCO GU: Advances in prostate cancer from day one
Alisertib for pretreated urothelial cancer
Link between non-aspirin NSAID use and risk of developing renal cell cancer
Brentuximab vedotin as salvage therapy for men with relapsed germ-cell tumours
Actionable targets in patients with cisplatin-resistant advanced germ cell tumours
The work and aims of the Association of Cancer Physicians
Breast cancer screening in Morocco
Post-translational modification (PTM) profiling – a novel tool for mapping the PTM landscape in cancer
EurocanPlatform 'Biomarkers, screening and prevention in cancer' Special Issue
What does the iManageCancer project hope to achieve?
Medical cancer prevention